The dynamics of the T-cell antitumor response: Chemokine-secreting dendritic cells can prime tumor-reactive T cells extranodally

C. J. Kirk, D. Hartigan-O'Connor, Dennis Hartigan-O'Connor

Research output: Contribution to journalArticle

100 Citations (Scopus)

Abstract

Direct administration of dendritic cells (DCs) genetically modified to express secondary lymphoid tissue chemokine (SLC) into growing B16 melanoma could result in a substantial, sustained influx of T cells within the mass with only a transient increase in T-cell numbers in the draining lymph node (DLN). DCs were retained at the tumor site with only a very small percentage trafficking to the DLN. The T cells infiltrating the tumor mass expressed the activation marker CD25 within 24 h and developed IFN-γ-secreting function within 7 days as tumor growth was inhibited. Similar results were obtained in lymphotoxin α-/- mice, which lacked peripheral lymph nodes. Our data demonstrate that effective T-cell priming can occur extranodally and result in measurable antitumor effects in vivo.

Original languageEnglish (US)
Pages (from-to)8794-8802
Number of pages9
JournalCancer Research
Volume61
Issue number24
StatePublished - Dec 15 2001
Externally publishedYes

Fingerprint

Chemokines
Dendritic Cells
T-Lymphocytes
Lymph Nodes
Neoplasms
Chemokine CCL21
Lymphotoxin-alpha
Experimental Melanomas
Cell Count
Growth

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

The dynamics of the T-cell antitumor response : Chemokine-secreting dendritic cells can prime tumor-reactive T cells extranodally. / Kirk, C. J.; Hartigan-O'Connor, D.; Hartigan-O'Connor, Dennis.

In: Cancer Research, Vol. 61, No. 24, 15.12.2001, p. 8794-8802.

Research output: Contribution to journalArticle

@article{8bb4ec849eae4383a0e95dc45e75b049,
title = "The dynamics of the T-cell antitumor response: Chemokine-secreting dendritic cells can prime tumor-reactive T cells extranodally",
abstract = "Direct administration of dendritic cells (DCs) genetically modified to express secondary lymphoid tissue chemokine (SLC) into growing B16 melanoma could result in a substantial, sustained influx of T cells within the mass with only a transient increase in T-cell numbers in the draining lymph node (DLN). DCs were retained at the tumor site with only a very small percentage trafficking to the DLN. The T cells infiltrating the tumor mass expressed the activation marker CD25 within 24 h and developed IFN-γ-secreting function within 7 days as tumor growth was inhibited. Similar results were obtained in lymphotoxin α-/- mice, which lacked peripheral lymph nodes. Our data demonstrate that effective T-cell priming can occur extranodally and result in measurable antitumor effects in vivo.",
author = "Kirk, {C. J.} and D. Hartigan-O'Connor and Dennis Hartigan-O'Connor",
year = "2001",
month = "12",
day = "15",
language = "English (US)",
volume = "61",
pages = "8794--8802",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "24",

}

TY - JOUR

T1 - The dynamics of the T-cell antitumor response

T2 - Chemokine-secreting dendritic cells can prime tumor-reactive T cells extranodally

AU - Kirk, C. J.

AU - Hartigan-O'Connor, D.

AU - Hartigan-O'Connor, Dennis

PY - 2001/12/15

Y1 - 2001/12/15

N2 - Direct administration of dendritic cells (DCs) genetically modified to express secondary lymphoid tissue chemokine (SLC) into growing B16 melanoma could result in a substantial, sustained influx of T cells within the mass with only a transient increase in T-cell numbers in the draining lymph node (DLN). DCs were retained at the tumor site with only a very small percentage trafficking to the DLN. The T cells infiltrating the tumor mass expressed the activation marker CD25 within 24 h and developed IFN-γ-secreting function within 7 days as tumor growth was inhibited. Similar results were obtained in lymphotoxin α-/- mice, which lacked peripheral lymph nodes. Our data demonstrate that effective T-cell priming can occur extranodally and result in measurable antitumor effects in vivo.

AB - Direct administration of dendritic cells (DCs) genetically modified to express secondary lymphoid tissue chemokine (SLC) into growing B16 melanoma could result in a substantial, sustained influx of T cells within the mass with only a transient increase in T-cell numbers in the draining lymph node (DLN). DCs were retained at the tumor site with only a very small percentage trafficking to the DLN. The T cells infiltrating the tumor mass expressed the activation marker CD25 within 24 h and developed IFN-γ-secreting function within 7 days as tumor growth was inhibited. Similar results were obtained in lymphotoxin α-/- mice, which lacked peripheral lymph nodes. Our data demonstrate that effective T-cell priming can occur extranodally and result in measurable antitumor effects in vivo.

UR - http://www.scopus.com/inward/record.url?scp=0035893749&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035893749&partnerID=8YFLogxK

M3 - Article

C2 - 11751401

AN - SCOPUS:0035893749

VL - 61

SP - 8794

EP - 8802

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 24

ER -